Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase Ib/II trial of GBR-1302

Trial Profile

A Phase Ib/II trial of GBR-1302

Phase of Trial: Phase I/II

Latest Information Update: 01 Jun 2018

At a glance

  • Drugs GBR 1302 (Primary)
  • Indications Breast cancer; Solid tumours
  • Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
  • Most Recent Events

    • 01 Jun 2018 New trial record
    • 25 May 2018 According to a Glenmark Pharmaceuticals media release, this trial will include an expansion cohort of HER2 positive metastatic breast cancer patients.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top